Protocol for measuring antibody-dependent enhancement and neutralization using reporter virus particles

Reporter virus particles (RVPs) are non-replicative, antigenically equivalent viral particles that enable BSL-2-compliant virology research using standard optical detection instrumentation. Here, we present a protocol for measuring neutralization and antibody-dependent enhancement (ADE) of flavivirus infection using dengue virus (DENV) RVPs. For both neutralization and ADE assays, we describe the steps for preparing sera and antibodies, pre-incubating with RVPs to allow immune complex formation, applying to BHK DC-SIGN or K562 cells, and quantifying reporter signal as a readout of viral entry. For complete details on the use and execution of this protocol, please refer to Grinyo-Escuer et al. 1 1. Grinyo-Escuer, A. ∙ Reddy, S. ∙ Chenine, A.L. ... Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine Cell Rep. 2025; 44 , 116098 Full Text Full Text (PDF) Scopus (2) PubMed Google Scholar

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2026-11-18
DOI
https://doi.org/10.1016/j.xpro.2026.104970
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Protocol for measuring antibody-dependent enhancement and neutralization using reporter virus particles

Nolan Frey, Nathan A. Krump, Benjamin J. Doranz, Allison Sheetz
STAR Protocols
Mosquito-borne diseases and control
article

Protocol for measuring antibody-dependent enhancement and neutralization using reporter virus particles

Nolan Frey, Nathan A. Krump, Benjamin J. Doranz, Allison Sheetz
article en

Abstract

Reporter virus particles (RVPs) are non-replicative, antigenically equivalent viral particles that enable BSL-2-compliant virology research using standard optical detection instrumentation. Here, we present a protocol for measuring neutralization and antibody-dependent enhancement (ADE) of flavivirus infection using dengue virus (DENV) RVPs. For both neutralization and ADE assays, we describe the steps for preparing sera and antibodies, pre-incubating with RVPs to allow immune complex formation, applying to BHK DC-SIGN or K562 cells, and quantifying reporter signal as a readout of viral entry. For complete details on the use and execution of this protocol, please refer to Grinyo-Escuer et al. 1 1. Grinyo-Escuer, A. ∙ Reddy, S. ∙ Chenine, A.L. ... Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine Cell Rep. 2025; 44 , 116098 Full Text Full Text (PDF) Scopus (2) PubMed Google Scholar

STAR ProtocolsVol. 7(4)
Integral Molecular (United States) (US)
National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon